Financials in GBp. Standardized financial statements.
A compact view of how Tissue Regenix Group plc turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £28.65M | £29.49M | £24.48M | £19.75M | £12.83M | £13.03M | £11.62M | £5.23M | £1.57M | £1.16M |
| Revenue Growth? | -2.9% | +20.5% | +24.0% | +53.9% | -1.6% | +12.2% | +122.0% | +232.4% | +35.5% | 0.0% |
| Cost of Revenue? | £15.03M | £15.45M | £10.73M | £8.73M | £7.70M | £8.06M | £6.88M | £3.11M | £714,546 | £219,326 |
| Gross Profit? | £13.62M | £14.04M | £9.14M | £5.63M | £5.13M | £4.97M | £4.74M | £2.12M | £859,637 | £942,818 |
| Gross Margin? | +47.5% | +47.6% | +37.3% | +28.5% | +40.0% | +38.1% | +40.8% | +40.6% | +54.6% | +81.1% |
| Operating Expenses? | £13.27M | £14.43M | £10.75M | £8.61M | £20.15M | £12.15M | £12.96M | £11.58M | £13.05M | £15.53M |
| Operating Income? | £349,000 | -£394,000 | -£2.01M | -£4.38M | -£4.12M | -£7.18M | -£8.21M | -£9.45M | -£12.19M | -£14.59M |
| EBITDA? | £1.36M | £446,000 | -£1.04M | -£3.04M | -£9.03M | -£6.13M | -£7.04M | -£8.75M | -£11.61M | -£14.24M |
| Income Before Tax | -£564,000 | -£1.67M | -£2.83M | -£5.14M | -£10.24M | -£7.66M | -£8.88M | -£10.77M | -£11.94M | -£14.28M |
| Income Tax Expense | £289,000 | -£12,000 | -£232,000 | -£157,000 | -£533,000 | -£554,000 | -£620,000 | -£1.35M | -£1.13M | -£750,551.876 |
| Net Income? | -£713,000 | -£1.71M | -£2.69M | -£4.79M | -£9.71M | -£6.97M | -£8.19M | -£9.22M | -£10.68M | -£13.40M |
| EPS? | £-0.01 | £-0.02 | £-0.03 | £-0.07 | £-0.28 | £-0.60 | £-0.70 | £-1.00 | £0.00 | £-1.80 |
| Diluted EPS? | £-0.01 | £-0.02 | £-0.03 | £-0.07 | £-0.28 | £-0.60 | £-0.70 | £-1.00 | £0.00 | £-1.80 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality